Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -176.1% | +543.1% | 2 / 3 | +125.5% | -1.50 pp | -0.62 pp | +5.7% | 0.65 | 21.96 | 90.003 | +125,5% | −95,4 | −146,3% | 21.96 | 22.87 | −4,0% |
| Pts | 0 | 12 | 8 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 12.900 (close price on 2026-10-19)EPS (TTM): 587,5
Financial charts
1.Revenue & growth
VND bn91.705Q2/26
1.Revenue & growth
VND bn91.705Q2/26
2.Profit & growth
VND bn-132Q2/26
3.Profit mix (Penman)
VND bn1.025Q2/26
4.Margins & cost structure
%2.8%Q2/26
5.Returns & cash cycle
% · days23.3%Q2/26
6.Earnings quality & cash
VND bn2.007Q2/26
7.Asset structure
VND bn53.264Q2/26
8.Funding & debt health
VND bn · times53.264Q2/26
9.Revenue backlog
VND bn177Q2/26
10.Valuation
times · %21,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-128Q2/26
Adjusted EPS growth, latest quarter
-174%
Average adjusted EPS growth, 3 quarters
544%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26